Metro Hospitals & Heart Institute

Name :

Metro Hospitals & Heart Institute

Address  :

14, Ring Road
Lajpat Nagar-IV

Town  :

New Delhi

State  :

Delhi

Country  :

INDIA

Post Code:

110 024

Phone  :

011-26442277, 26237963

Fax  :

011 26481356

Web URL  :

Metro Hospitals  Heart Institute
Specialization
  • Anaesthesiology
  • Cardiology
  • Gastro-enterology
  • Psychiatrist
  • Pulmonology
Facilities

Total Number Of Beds : 50

Speciality Type :

  • Single Speciality : Cardiothoracic Surgery

Other Facilities

  • Pathology
  • X-Ray

Other Mode Of Therapies

  • Homopathy
  • Physiotherapy

Advance Facility

  • Blood Bank

Description

Metro Hospital amp Heart Institute strives to provide patients with expert treatment and care over the past 10 years We believe in offering the patients with an ethical and open environment to recover and ultra modern 24 x 7 facilities handled by renowned cardiologists cardiothoracic surgeons and anesthetists The scorecard shows an unmatched record of heart surgeries which include bypass surgeries complicated coronary artery bypass surgery surgery of all valvular heart disease with success rates comparable to international standards Our surgeons are recognized all over the world for innovative new approaches refining their skills from routine cardiac procedures to minimally invasive cardiac surgeries The commitment of our cardiologists and cardiothoracic surgeons to the prevention and treatment of heart disease has led to the achievement of better outcomes and improved quality of life for thousands of cardiac patients who visit us each year
All is not well in Govt Psychiatric Hospital

Srinagar May 27 Jammu and Kashmir State Human Rights Commission SHRC has castigated the State Government over poor patient care and lack of basic amenities at the Valleys sole Government Psychiatric Hospital and recommended immediate measures to improve its functioning The Commission has sent a comprehensive report to the Government of India reg... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More